![](/documents/10803/1056866/Sleep+apnea+treatment+reduces+heart+problems+in+patients+with+prediabetes%2C+a+new+study+finds+thumbnail.jpg/b351cbe2-ec4a-fb2e-104b-992a226e614c?t=1601574765638)
Sleep apnea treatment reduces heart problems in patients with prediabetes, a new study finds
People with prediabetes and obstructive sleep apnea could reduce their daytime resting heart rate and risk of cardiovascular disease by using a CPAP machine at night
![](/documents/10803/1033543/Nip+it+in+the+bud+New+study+will+attack+SARS-Cov2+where+it+multiplies_thumbnail.jpg/6b974138-58e4-d1df-8683-7895cd0478e7?t=1600286412235)
Nip it in the bud: New study will attack SARS-Cov2 where it multiplies
RI-MUHC researchers initiate a clinical trial of ciclesonide to possibly prevent mild cases of COVID-19 from worsening
![](/documents/10803/1044530/RI-MUHC+researcher+Maziar+Divangahi+honoured+by+the+Royal+Society+of+Canada+thumbnail.jpg/df8edfa4-702a-f220-9363-e1f292b34f31?t=1600276913080)
RI-MUHC researcher Maziar Divangahi honoured by the Royal Society of Canada
Recognition for high-level achievement in research into pulmonary infectious diseases
![](/documents/10803/1033543/Systematic+testing+of+groups+at+increased+risk+of+SARS-CoV-2+an+affordable+and+reasonable+approach+thumbnail.jpg/c4a00945-791d-0d1e-2fec-e45f9f00a213?t=1599747921644)
Systematic testing of groups at increased risk of SARS-CoV-2: an affordable and reasonable approach
In a new cost-analysis study, researchers recommend widespread testing of...
![](/documents/10803/1033543/Old+drug%2C+new+therapy+RI-MUHC-sponsored+phase+III+clinical+trial+ready+to+test+repurposed+dapsone+to+tone+down+lung+inflammation+caused+by+COVID-19+thumbnail.jpg/572e3c50-5118-08f1-5bd6-2a307d306168?t=1599051643192)
Old drug, new therapy: RI-MUHC-sponsored phase III clinical trial ready to test repurposed dapsone to tone down lung inflammation caused by COVID-19
Reformulated and patented version of well-known generic drug could prove to be a quick, safe and cost-effective way to accelerate recovery and prevent hospitalizations
![](/documents/10803/1014936/Research+suggests+greater+access+to+specific+HIV+and+tuberculosis+medications+is+needed+worldwide+thumbnail.jpg/63723583-8675-f810-4f52-b4a6c12d9e90?t=1598368095118)
Research suggests greater access to specific HIV and tuberculosis medications is needed worldwide
Postdoctoral fellows at the RI-MUHC carried out primary statistical analyses for study published in The Lancet
![](/documents/10803/1014141/Canada+Research+Chairs+Program+announces+new+and+renewed+chairs+thumbnail.jpg/964b7410-9d6b-d68d-9474-636e03fa0355?t=1596737371968)
Canada Research Chairs Program announces new and renewed chairs
Congratulations to five RI-MUHC researchers in the spring 2020 round!
![](/documents/10803/993134/Mikashmi-thumbnail.jpg)
Recipient of the 2020-2021 Dr. Margaret Becklake Fellowship: Mikashmi Kohli
A postdoctoral fellow from the RI-MUHC is recognized for international work on TB diagnostics
![](/documents/10803/941785/Three+COVID-19+projects+at+the+RI-MUHC+to+receive+CIHR+funding+thumbnail.jpg/35299054-b9e1-cf5e-72b3-82cb85e06725?t=1593193199353)
Three COVID-19 projects at the RI-MUHC to receive CIHR funding
A $109M fund aims to mitigate impact of the pandemic on care delivery in Canada and beyond, as well as contribute to better understanding of the disease
![](/documents/10803/946541/Rifampin+for+Latent+TB+Shorter+and+safer+than+the+standard+treatment%2C+but+also+cheaper+thumbnail.jpg/354075da-d64f-f8bf-9784-4c73dfa292c3?t=1592425697161)
Rifampin for Latent TB: Shorter and safer than the standard treatment, but also cheaper
A new study shows that rifampin regimen is cheaper than isoniazid for latent tuberculosis